Downregulation of microRNA-142 by proto-oncogene LMO2 and its co-factors
W Yuan,W Sun,S Yang,J Du,C-L Zhai,Z-Q Wang,J Zhang,T-H Zhu
DOI: https://doi.org/10.1038/sj.leu.2405001
2007-01-01
Leukemia
Abstract:Hematopoiesis is a tightly regulated multistage process. In the past decade, a number of transcription factors have been identified as crucial regulators in cell proliferation, differentiation and apoptosis in hematopoiesis. The proto-oncogene, LMO2 (also named rbtn2 or ttg2), is such a factor. LMO2 was first cloned from an acute T-lymphocyte leukemia (T-ALL) patient with a (11;14;p13;q11) translocation,1 and subsequently showed crucial functions in hematopoiesis, as well as in angiogenesis.2, 3 LMO2 encodes a LIM-only protein comprised of two LIM domains characterized as a cysteine-rich motif consisting of two tandemly repeated zinc fingers and is considered to be a transcriptional regulator through the interactions with its partners, including LDB1 (CLIM2/NLI1), GATA1, TAL1(SCL) and E47, to form a multi-complex in which LMO2 functions as a bridging molecule with the two arms of GATA1 and TAL1/E47 bound to relevant DNA motifs.4 MicroRNAs (miRNAs) are a recently discovered class of small (22-nt), non-coding RNAs that regulate gene expression via the RNA interference pathway either to promote degradation of the target mRNA or to repress its translation. There was increasing evidence showing that miRNAs had crucial functions in hematopoiesis, as well as leukemia (reviewed in Ref. 5). However, there were only a few reports about the expression profiles of miRNAs, and studies on miRNA expression regulations in hematopoiesis are limited. Until now, the best studied is miR-223, which has been shown to be regulated by C/EBP6, PU.1 and GATA1.7 MiR-142, which was confirmed to have similar functions with miR-223 in promoting T-cell development, has rarely been studied before. In this study, we analyzed miR-142 expression profiles in the human erythroid/myeloid leukemia cell line, K562, the human T-cell lymphoblast-like cell line, Jurkat, and the Burkitt lymphoma cell line, Raji, by semi-quantitative RT–PCR. MiR-142 was detected in all these cell lines. We then analyzed LMO2 mRNA levels by semi-quantitative RT–PCR and LMO2 protein expression by immunoblot analysis in these cell lines. We found that LMO2 expression (both mRNA and protein) was absent in Jurkat cells, which expressed high levels of miR-142. In contrast, the other two cell lines that expressed high levels of LMO2 showed reduced miR-142 expression (Figure 1). These data suggested that there might be some relationship between miR-142 and LMO2. To identify possible regulators of miR-142 expression, we cloned a 2320 bp region 5' flanking of pre-miR-142 from the human genome and then confirmed by sequencing, named N1 (- 2320 to - 1 bp). Then a set of 5' deletions were performed according to the restriction sites that were suitable for insertions to pGL4 vector and another two reporter constructs, named N2 (- 1274 to - 1 bp) and N3 (- 1144 to - 1 bp), were generated. These constructs were assayed in transient transfection experiments in K562 and control (HEK293) cell lines. All these reporters showed potent promoter activity in K562 cells, in which the miR-142 gene was endogenously expressed. However, the reporters were virtually silent in the control cell line. One notable thing was that the promoter activity was significantly increased when the - 2320 to - 1274 region was deleted. This indicated that this region might contain some repressor elements contributing to the regulating miR-142 expression in K562 cells (Figure 2b). The putative binding sites for transcription factors were explored in this region using the Transcription Element Search System (URL: http://www.cbil.upenn.edu/tess). Notably, one putative GATA-binding site and an E-box (CACGTG) on the transcriptional minus strand were found. The distance between the E-box and the GATA site in this bipartite sequence was 9 bp, similar to the bipartite DNA-binding motif present in the promoter of several hematopoietic-specific genes found to be directly regulated by the LMO2 complex.8 In addition, there were also two predicted transcriptional start sites in this region, as shown in Figure 2a (committed by NNPP Neural Network Promoter Prediction; http://www.fruitfly.org/seq_tools/promoter.html), but they seemed to contribute with no prominent difference to the promoter activity (Figure 2b N2 and N3). To investigate whether LMO2 physically interacted with the miR-142 promoter region in vivo, we performed ChIP in K562 cells. Anti-LMO2 antibody, as well as anti-FLAG antibody used as a control, was used to immunoprecipitate the fragmented chromatin. After reversal of the crosslink, a segment of the miR-142 promoter (- 2000 to - 1703 bp, 298 bp) containing the E-box/GATA site was amplified by PCR using specific spanning primers. Primers recognizing the 3'-distal region were used as a negative control in the PCR reactions, as shown in Figure 3a. The result suggested that LMO2 could specifically bind to the - 2000 to - 1703 bp (298 bp) region of the miR-142 promoter (Figure 3b), providing strong evidence that LMO2 was involved in the regulation of the miR-142 gene. To further study, the regulatory effect of LMO2 on the miR142-promoter, we performed a LMO2 overexpression assay and knockdown assay using RNAi. The LMO2 siRNA construct (pSilencer4.1-siLMO2), or an unrelated control siRNA construct (pSilencer4.1-control), was transfected into K562 cells. LMO2 silencing efficiency was confirmed using western blot analysis and the results showed that the protein level was reduced to less than 20% (Figure 3b). In the same cell lysates, we found a dramatic increase of N1 reporter activity compared to the cells transfected with control siRNA. Meanwhile, we also found that when overexpressing LMO2 in K562 cells, the reporter activity decreased by about 50% (Figure 3a). According to our data, LMO2 appeared to play a pivotal function in negatively regulating the expression of miR-142. Some reports pointed out that LMO2 functioned as a bridging molecule to assemble TAL1, LDB1, E47 and GATA1 to form a DNA-binding complex; and in the complex, GATA1 and TAL1 could bind to their relevant DNA motifs, while LMO2 itself was considered having no DNA-binding ability.8 This reminded us that it probably also required the presence of GATA1, LDB1 and TAL1/E47, besides LMO2 to efficiently regulate the expression of miR-142. To investigate this question, we performed transactivation assays using K562 cells and the longest promoter reporter, N1, which contained the LMO2 complex-binding motif. Expression vectors for LMO2 and its partners, LDB1, GATA1, TAL1 and E47, were transfected separately or in combination to examine the function of these transcription factors on the promoter. The relative luciferase activity of single transfection with N1 reporter was marked as the control (100% ). As shown in Figure 4c, co-transfection of the N1 reporter with the LDB1, TAL1 or E47 expression vector did not prominently affect the reporter activity, whereas overexpression of GATA1 conferred a slight inhibitory effect and overexpression of LMO2 inhibited the N1 reporter activity to a modest degree, similar to the result shown in Figure 4a. Notably, when we co-expressed LMO2 with GATA1, TAL1, LDB1 and E47, the N1 reporter activity was repressed remarkably to 20% compared to the control, showing a synergistic pattern of these members. In addition, to detect the affect of LMO2 on endogenous miR-142 expression, we transiently transfected K562 cells with LMO2 expression vector alone, or the LMO2 complex including LMO2, GATA1, LDB1, TAL1 and E47 expression vectors, or the LMO2 siRNA construct, or the EGFP expression vector as a negative control. In cells overexpressing LMO2 or the LMO2 complex, the endogenous miR142 precursor expression levels were decreased significantly, whereas in the cells transfected with LMO2 siRNA construct, the miR142 precursor expression level showed a strong increase compared with the negative control (Figure 4d). These data confirmed that LMO2, together with its co-factors, could negatively regulate the expression of miR-142 in vivo. Previously, it was considered that the LMO2 complex customarily functioned by promoting the transcription of its target genes, and consequently upregulated a set of its downstream genes.4, 8 We reported here that miRNA-142 was regulated by LMO2 together with its co-factors in a negative manner. This result indicated that the LMO2 complex could inhibit the expression of some genes directly. Considering the ability of miR-142 on promoting T-cell development and the differentiation arrest caused by abnormal expression of LMO2 in T-cell leukemia, our findings might partially explain the pathologic mechanism of LMO2 in T-cell leukemia, that is, LMO2 might exhibit its oncogenic property through inhibiting the expression of miR-142. Recent studies described several miRNAs regulated by classic transcription factors. Our results showed that in hematopoiesis, miR-142 was also regulated by the transcriptional regulators, LMO2, LDB1, GATA1 and TAL1/E47, but in a negative manner. Thus, LMO2 and its co-factors may also play crucial roles in hematopoiesis by regulating the expression levels of miRNAs. This work was supported by the National Nature Science Foundation of China (No.30771054).